These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 26956801)

  • 1. Forkhead box transcription factor 1: role in the pathogenesis of diabetic cardiomyopathy.
    Kandula V; Kosuru R; Li H; Yan D; Zhu Q; Lian Q; Ge RS; Xia Z; Irwin MG
    Cardiovasc Diabetol; 2016 Mar; 15():44. PubMed ID: 26956801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forkhead box O1 transcription factor; a therapeutic target for diabetic cardiomyopathy.
    Shafaati T; Gopal K
    J Pharm Pharm Sci; 2024; 27():13193. PubMed ID: 39206323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exogenous hydrogen sulfide attenuates the development of diabetic cardiomyopathy via the FoxO1 pathway.
    Ye P; Gu Y; Zhu YR; Chao YL; Kong XQ; Luo J; Ren XM; Zuo GF; Zhang DM; Chen SL
    J Cell Physiol; 2018 Dec; 233(12):9786-9798. PubMed ID: 30078216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXO1 contributes to diabetic cardiomyopathy via inducing imbalanced oxidative metabolism in type 1 diabetes.
    Yan D; Cai Y; Luo J; Liu J; Li X; Ying F; Xie X; Xu A; Ma X; Xia Z
    J Cell Mol Med; 2020 Jul; 24(14):7850-7861. PubMed ID: 32450616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Foxo1 by insulin resistance promotes cardiac dysfunction and β-myosin heavy chain gene expression.
    Qi Y; Zhu Q; Zhang K; Thomas C; Wu Y; Kumar R; Baker KM; Xu Z; Chen S; Guo S
    Circ Heart Fail; 2015 Jan; 8(1):198-208. PubMed ID: 25477432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeutics.
    Jakubik D; Fitas A; Eyileten C; Jarosz-Popek J; Nowak A; Czajka P; Wicik Z; Sourij H; Siller-Matula JM; De Rosa S; Postula M
    Cardiovasc Diabetol; 2021 Feb; 20(1):55. PubMed ID: 33639953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential role of nuclear factor κB in diabetic cardiomyopathy.
    Lorenzo O; Picatoste B; Ares-Carrasco S; Ramírez E; Egido J; Tuñón J
    Mediators Inflamm; 2011; 2011():652097. PubMed ID: 21772665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KLF5 Is Induced by FOXO1 and Causes Oxidative Stress and Diabetic Cardiomyopathy.
    Kyriazis ID; Hoffman M; Gaignebet L; Lucchese AM; Markopoulou E; Palioura D; Wang C; Bannister TD; Christofidou-Solomidou M; Oka SI; Sadoshima J; Koch WJ; Goldberg IJ; Yang VW; Bialkowska AB; Kararigas G; Drosatos K
    Circ Res; 2021 Feb; 128(3):335-357. PubMed ID: 33539225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FoxO1 is crucial for sustaining cardiomyocyte metabolism and cell survival.
    Puthanveetil P; Wan A; Rodrigues B
    Cardiovasc Res; 2013 Mar; 97(3):393-403. PubMed ID: 23263330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QKI deficiency promotes FoxO1 mediated nitrosative stress and endoplasmic reticulum stress contributing to increased vulnerability to ischemic injury in diabetic heart.
    Guo W; Jiang T; Lian C; Wang H; Zheng Q; Ma H
    J Mol Cell Cardiol; 2014 Oct; 75():131-40. PubMed ID: 25068621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kir6.1 improves cardiac dysfunction in diabetic cardiomyopathy via the AKT-FoxO1 signalling pathway.
    Wang J; Bai J; Duan P; Wang H; Li Y; Zhu Q
    J Cell Mol Med; 2021 Apr; 25(8):3935-3949. PubMed ID: 33547878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status and strategies of long noncoding RNA research for diabetic cardiomyopathy.
    Pant T; Dhanasekaran A; Fang J; Bai X; Bosnjak ZJ; Liang M; Ge ZD
    BMC Cardiovasc Disord; 2018 Oct; 18(1):197. PubMed ID: 30342478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic stress-induced activation of FoxO1 triggers diabetic cardiomyopathy in mice.
    Battiprolu PK; Hojayev B; Jiang N; Wang ZV; Luo X; Iglewski M; Shelton JM; Gerard RD; Rothermel BA; Gillette TG; Lavandero S; Hill JA
    J Clin Invest; 2012 Mar; 122(3):1109-18. PubMed ID: 22326951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.
    Palomer X; Salvadó L; Barroso E; Vázquez-Carrera M
    Int J Cardiol; 2013 Oct; 168(4):3160-72. PubMed ID: 23932046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy.
    Frati G; Schirone L; Chimenti I; Yee D; Biondi-Zoccai G; Volpe M; Sciarretta S
    Cardiovasc Res; 2017 Mar; 113(4):378-388. PubMed ID: 28395009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoamine oxidase-A is an important source of oxidative stress and promotes cardiac dysfunction, apoptosis, and fibrosis in diabetic cardiomyopathy.
    Umbarkar P; Singh S; Arkat S; Bodhankar SL; Lohidasan S; Sitasawad SL
    Free Radic Biol Med; 2015 Oct; 87():263-73. PubMed ID: 26122707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of Diabetic Cardiomyopathy and Role of miRNA.
    Ahmed U; Khaliq S; Ahmad HU; Ahmad I; Ashfaq UA; Qasim M; Masoud MS
    Crit Rev Eukaryot Gene Expr; 2021; 31(1):79-92. PubMed ID: 33639058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of non-coding RNA in diabetic cardiomyopathy.
    Yao X; Huang X; Chen J; Lin W; Tian J
    Cardiovasc Diabetol; 2024 Jun; 23(1):227. PubMed ID: 38951895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological Effects of Exosomes in Mediating Diabetic Cardiomyopathy.
    Salem ESB; Fan GC
    Adv Exp Med Biol; 2017; 998():113-138. PubMed ID: 28936736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opening of mitoKATP improves cardiac function and inhibits apoptosis via the AKT-Foxo1 signaling pathway in diabetic cardiomyopathy.
    Duan P; Wang J; Li Y; Wei S; Su F; Zhang S; Duan Y; Wang L; Zhu Q
    Int J Mol Med; 2018 Nov; 42(5):2709-2719. PubMed ID: 30132505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.